Prescott Group Capital Management L.L.C. reduced its position in shares of OR Royalties Inc. (NYSE:OR – Free Report) by 13.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 248,000 shares of the basic materials company’s stock after selling 40,000 shares during the period. OR Royalties makes up about 0.8% of Prescott Group Capital Management L.L.C.’s portfolio, making the stock its 23rd biggest holding. Prescott Group Capital Management L.L.C. owned approximately 0.13% of OR Royalties worth $8,777,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in the company. HighTower Advisors LLC lifted its holdings in OR Royalties by 6.4% during the 4th quarter. HighTower Advisors LLC now owns 84,597 shares of the basic materials company’s stock worth $2,994,000 after purchasing an additional 5,079 shares during the last quarter. Dana Investment Advisors Inc. acquired a new stake in OR Royalties during the 4th quarter worth approximately $847,000. Allworth Financial LP lifted its holdings in OR Royalties by 20.0% during the 4th quarter. Allworth Financial LP now owns 2,305 shares of the basic materials company’s stock worth $82,000 after purchasing an additional 384 shares during the last quarter. Independent Advisor Alliance acquired a new stake in OR Royalties during the 4th quarter worth approximately $2,147,000. Finally, Versor Investments LP acquired a new stake in OR Royalties during the 4th quarter worth approximately $485,000. 68.52% of the stock is owned by institutional investors and hedge funds.
OR Royalties Stock Up 1.4%
OR stock opened at $36.00 on Thursday. OR Royalties Inc. has a 12 month low of $24.42 and a 12 month high of $48.06. The firm has a market cap of $6.75 billion, a P/E ratio of 26.86 and a beta of 0.71. The company’s 50-day moving average price is $38.55 and its two-hundred day moving average price is $38.41.
OR Royalties Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.065 per share. This is an increase from OR Royalties’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.7%. OR Royalties’s payout ratio is presently 16.42%.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on OR shares. Scotiabank lifted their price target on OR Royalties from $41.00 to $51.00 and gave the stock a “sector perform” rating in a report on Monday, January 26th. TD Securities restated a “hold” rating on shares of OR Royalties in a research note on Monday, February 23rd. Wall Street Zen lowered OR Royalties from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. Zacks Research lowered OR Royalties from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, March 31st. Finally, Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of OR Royalties in a research note on Wednesday, February 4th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat, OR Royalties presently has a consensus rating of “Moderate Buy” and an average target price of $46.50.
Check Out Our Latest Stock Analysis on OR Royalties
About OR Royalties
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
See Also
- Five stocks we like better than OR Royalties
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
